| Bioactivity | (Rac)-Eflucimibe ((Rac)-F 12511) is an ACAT inhibitor with endogenous hypercholesterolemia modulating activity. (Rac)-Eflucimibe has shown high potency and efficacy as an anti-hypercholesterol compound in different hypercholesterolemia animal models[1]. |
| CAS | 191791-65-8 |
| Formula | C29H43NO2S |
| Molar Mass | 469.72 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Time-dependent evaluation of mechanical properties and in vitro cytocompatibility of experimental composite-based nerve guidance conduits |
(Rac)-Eflucimibe
CAS: 191791-65-8 F: C29H43NO2S W: 469.72
(Rac)-Eflucimibe ((Rac)-F 12511) is an ACAT inhibitor with endogenous hypercholesterolemia modulating activity. (Rac)-Ef
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.